Metabolon

company

About

Metabolon develops analytical methods and software for biomarker discovery by using metabolomics.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$8M
Industries
Biotechnology,Health Care,Health Diagnostics,Software
Founded date
Jan 1, 2000
Number Of Employee
101 - 250
Operating Status
Active

Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine.

The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions.

Metabolon was founded in 2000 and headquartered in Durham, North Carolina.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$22.25M
Metabolon has raised a total of $22.25M in funding over 2 rounds. Their latest funding was raised on Oct 27, 2009 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 27, 2009 Series C $6.20M 1 Detail
Mar 27, 2008 Series C $3.05M 1 Detail
Jan 18, 2006 Series B $8M 1 Detail
Oct 13, 2004 Series A $5M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Metabolon is funded by 1 investors. The Trelys Funds are the most recent investors.
Investor Name Lead Investor Funding Round
The Trelys Funds Series C